found that leptin-mediated tamoxifen resistance of BC was correlated with the activation of ERK1/2 and STAT3 signaling and overexpression of cyclin D1 in MCF-7 BC cells by binding to ObRb (139). This evidence concerns the gene LEP and breast cancer.